CN103041166A - Chinese medicament for treating pharyngitis - Google Patents

Chinese medicament for treating pharyngitis Download PDF

Info

Publication number
CN103041166A
CN103041166A CN2013100137334A CN201310013733A CN103041166A CN 103041166 A CN103041166 A CN 103041166A CN 2013100137334 A CN2013100137334 A CN 2013100137334A CN 201310013733 A CN201310013733 A CN 201310013733A CN 103041166 A CN103041166 A CN 103041166A
Authority
CN
China
Prior art keywords
gram
grams
radix
pharyngitis
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100137334A
Other languages
Chinese (zh)
Other versions
CN103041166B (en
Inventor
刘国存
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310013733.4A priority Critical patent/CN103041166B/en
Publication of CN103041166A publication Critical patent/CN103041166A/en
Application granted granted Critical
Publication of CN103041166B publication Critical patent/CN103041166B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating pharyngitis, and the Chinese medicament can be used for effectively solving the problem of the medicament for treating the pharyngitis. The technical scheme for solving the problem is as follows: the medicament consists of the following bulk drugs: 6-18g of manis pentadactyla, 9-12g of blackberry lily, 6-15g of mangnolia officinalis, 9-12g of platycodon grandiflorum, 6-10g of burdock, 8-15g of subprostrate sophora, 6-12g of paris polyphylla sm., 9-12g of adenophora stricta, 6-10g of radix polygonati officinalis, 6-12g of radix scrophulariae and 8-12g of oroxylum seeds. The bulk drugs are ground to be 80-120 meshes of fine powder, and are filled into a capsule 0.5g for each; and moreover, the medicament is rich in raw materials, easy to produce, low in cost and convenient to orally take, can be effectively used for treating the pharyngitis, and has a good effect; and therefore, the medicament is a creative Chinese medicament for treating the pharyngitis.

Description

A kind of Chinese medicine for the treatment of pharyngitis
Technical field
The present invention relates to medicine, particularly a kind of Chinese medicine for the treatment of pharyngitis.
Background technology
The traditional Chinese medical science thinks that the pathological changes of pharyngitis is throat, but its pathology formation and lung, liver, stomach, kidney have substantial connection.Therefore pharyngitis can not be anxious for success and with the Western medicine of some anti-inflammatory types.The chronic pharyngitis etiology and pathogenesis often is that internal organs are deficient, and the consumption impairment of YIN is divided, and hyperactivity of deficient fire causes in throat, or repeatedly shows effect because of acute pharyngitis due to wind-heat, remaining evil delay the, or dust, foul smell stimulates, and the hobby tobacco and wine are pungent, impairment caused by overstrain excessively waits and causes, deficiency of lung-YIN is deficiency of body fluid then, and it is foster that throat loses in moistening, and furthermore asthenic fire is followed through upper inflammation; Deficiency of the kidney yin, network is in lung on the passages through which vital energy circulates of kidney, and deficiency of the kidney yin whenever causes the also deficiency of YIN of lung, and hyperactivity of deficient fire is satisfied to sore throat.In addition, steam on the asthenic fire, bright Tianjin becomes expectorant, in addition venation numbness resistance, and disorder of QI movement causes stagnation of QI expectorant solidifying, phlegm-fire pent-up.
Throat is the door of lung stomach, such as the lung stomach intrinsic heat is arranged, and is burning hot scorching, and QI and blood is tied in throat, visible local chronic congestion, and mucosa is dry and fall ill.Other deficiency of kidney-YIN, hyperactivity of deficient fire, dry laryngopharynx, snoring can be sent out for a long time and also and is pharyngitis.
Whether can the Chinese traditional treatment method very cure pharyngitis? in current clinical medicine, using the treatment by Chinese herbs pharyngitis is take the Chinese medical discrimination theory as the basis, and take YIN nourishing increase liquid, nourishing the lung and kidney, removing heat-phlegm, the sore-throat relieving that wets one's whistle is as the primary treatment purpose.In pharyngitis patient's clinical treatment, the treatment by Chinese herbs method has progressively represented powerful development potentiality.But Chinese medicine is difficult to incorporate modern's life because of the existence edible bottleneck of boiling medicine, a lot of people or be main mainly with Western medicine, because the pharyngitis patient is in the western medicine process, the abuse of each antibiotics very easily causes patient's taste to be subject to major injury.And the spleen being the foundation of acquired constitution, source of generating QI and blood, if insufficiency of the spleen biochemical not enough, then throat loses and supports, and the symptoms such as pharyngalgia, dry pharynx discomfort occur, affect the healthy of people, though existing have multiple treatment pharyngitis Chinese and western drugs, for various reasons, it uses and is unsatisfactory, therefore, the novel drugs of development treatment pharyngitis is imperative.
Summary of the invention
For above-mentioned situation, for overcoming the defective of prior art, the present invention's purpose just provides a kind of Chinese medicine for the treatment of pharyngitis, can effectively solve the medication problem for the treatment of pharyngitis.
The technical scheme that the present invention solves is, according to the Chinese medicine and pharmacy principle, take YIN nourishing increase liquid, nourishing the lung and kidney, removing heat-phlegm, the sore-throat relieving that wets one's whistle is as the Therapeutic Principle, accordingly, the present invention adopts following material medicine to form: Squama Manis 6--18 gram, Rhizoma Belamcandae 9--12 gram, Cortex Magnoliae Officinalis 6--15 gram, Radix Platycodonis 9--12 gram, Fructus Arctii 6--10 gram, Radix Sophorae Tonkinensis 8--15 gram, Rhizoma Paridis 6--12 gram, Radix Adenophorae (Radix Glehniae) 9--12 gram, Rhizoma Polygonati Odorati 6--10 gram, Radix Scrophulariae 6--12 gram, Semen Oroxyli 8--12 gram, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
Abundant raw material of the present invention is easily produced, and cost is low, and taking convenience is effective, is effective to treat pharyngitis, is the innovation on the treatment pharyngitis medicine.
The specific embodiment
Below in conjunction with embodiment the specific embodiment of the present invention is elaborated.
Embodiment 1
The present invention in force, can be formed by following material medicine: Squama Manis 6-10 gram, Rhizoma Belamcandae 9-10 gram, Cortex Magnoliae Officinalis 6-8 gram, Radix Platycodonis 9-10 gram, Fructus Arctii 6-7 gram, Radix Sophorae Tonkinensis 8-10 gram, Rhizoma Paridis 6-8 gram, Radix Adenophorae (Radix Glehniae) 9-10 gram, Rhizoma Polygonati Odorati 6-7 gram, Radix Scrophulariae 6-8 gram, Semen Oroxyli 8-9 gram, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
Embodiment 2
The present invention in force, also can be formed by following material medicine: Squama Manis 11-15 gram, Rhizoma Belamcandae 11-12 gram, Cortex Magnoliae Officinalis 9-12 gram, Radix Platycodonis 11-12 gram, Fructus Arctii 8-9 gram, Radix Sophorae Tonkinensis 10-12 gram, Rhizoma Paridis 9-10 gram, Radix Adenophorae (Radix Glehniae) 11-12 gram, Rhizoma Polygonati Odorati 8-9 gram, Radix Scrophulariae 9-10 gram, Semen Oroxyli 10-12 gram, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
Embodiment 3
The present invention in force, can be formed by following raw material Chinese medicine: Squama Manis 16-18 gram, Rhizoma Belamcandae 12 grams, Cortex Magnoliae Officinalis 13-15 gram, Radix Platycodonis 12 grams, Fructus Arctii 10 grams, Radix Sophorae Tonkinensis 13-15 gram, Rhizoma Paridis 11-12 gram, Radix Adenophorae (Radix Glehniae) 12 grams, Rhizoma Polygonati Odorati 10 grams, Radix Scrophulariae 11-12 gram, Semen Oroxyli 11.5 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
Embodiment 4
The present invention in force, can be formed by following raw material Chinese medicine: Squama Manis 8 grams, Rhizoma Belamcandae 9 grams, Cortex Magnoliae Officinalis 1 gram, Radix Platycodonis 9 grams, Fructus Arctii 7 grams, Radix Sophorae Tonkinensis 9 grams, Rhizoma Paridis 7 grams, Radix Adenophorae (Radix Glehniae) 9 grams, Rhizoma Polygonati Odorati 7 grams, Radix Scrophulariae 7 grams, Semen Oroxyli 9 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
Embodiment 5
The present invention in force, can be formed by following raw material Chinese medicine: Squama Manis 13 grams, Rhizoma Belamcandae 10 grams, Cortex Magnoliae Officinalis 10.5 grams, Radix Platycodonis 10 grams, Fructus Arctii 8 grams, Radix Sophorae Tonkinensis 11.5 grams, Rhizoma Paridis 9.5 grams, Radix Adenophorae (Radix Glehniae) 10 grams, Rhizoma Polygonati Odorati 8 grams, Radix Scrophulariae 9.5 grams, Semen Oroxyli 10 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
Embodiment 6
The present invention in force, can be formed by following raw material Chinese medicine: Squama Manis 17 grams, Rhizoma Belamcandae 11 grams, Cortex Magnoliae Officinalis 14 grams, Radix Platycodonis 11 grams, Fructus Arctii 9 grams, Radix Sophorae Tonkinensis 14 grams, Rhizoma Paridis 11.5 grams, Radix Adenophorae (Radix Glehniae) 11 grams, Rhizoma Polygonati Odorati 9 grams, Radix Scrophulariae 11.5 grams, Semen Oroxyli 11 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
At the above-mentioned raw materials medicine, wherein:
Squama Manis: return liver, stomach warp; Blood circulation promoting and dispersing pathogen accumulation, the stimulating milk secretion of stimulating the menstrual flow, eliminating carbuncle are burst hard;
Rhizoma Belamcandae: enter lung, Liver Channel, heat-clearing and toxic substances removing, throat, expectorant saliva;
Cortex Magnoliae Officinalis: return spleen channel, stomach warp, large intestine channel; The circulation of qi promoting removing food stagnancy, dampness is except expiring lowering the adverse QI to relieve asthma;
Radix Platycodonis: lung qi dispersing, eliminate the phlegm, sore-throat relieving, evacuation of pus, sharp the five internal organs, fill blood, mend five kinds of over strain, foster the spirit of nobility
Fructus Arctii: lung qi dispersing, eliminate the phlegm, sore-throat relieving, evacuation of pus, sharp the five internal organs, fill blood, mend five kinds of over strain, foster the spirit of nobility;
Radix Sophorae Tonkinensis: relieve inflammation or internal heat detoxifcation, detumescence, pain relieving;
Rhizoma Paridis: another name, Rhizoma Paridis, magnificent Rhizoma Paridis, seven Ye Lou, golden pan arrest Fructus Litchi, anticancer, the reducing swelling and alleviating pain of relieving internal heat, heat clearing away arresting convulsion, antitussive and antiasthmatic;
Radix Adenophorae (Radix Glehniae): another name Radix Adenophorae, bubble ginseng, bubble Radix Adenophorae (Radix Glehniae), clearing away heat and nourishing YIN, nourishing the lung to arrest cough;
Rhizoma Polygonati Odorati: nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid;
Radix Scrophulariae: another name, Radix Scrophulariae, clearing away heat and cooling blood, eliminating fire and detoxication, YIN nourishing;
Semen Oroxyli: lung moistening, soothing liver-QI, stomach function regulating, granulation promoting.
Effective combination of said medicine is supported mutually, has the effect that YIN nourishing increases liquid, nourishing the lung and kidney, removing heat-phlegm, the sore-throat relieving that wets one's whistle, and is effective to treat pharyngitis, and has obtained good useful technique effect through test, and interrelated data is as follows:
One, selects the standard of case
Pharyngitis is divided acute pharyngitis and chronic pharyngitis:
Acute pharyngitis (acute pharyngitis) is pharyngeal mucous membrane, and involve under the mucosa and adenoid acute inflammation, often be secondary to acute rhinitis (Acuterhinitis) or acute tonsil inflammation (tonsil inflammation) afterwards or be the part of upper respiratory tract infection (upper respiratory infection).Also often be the topical manifestations of general disease or be the prodrome of acute infectious disease.
Pharyngeal mucosa is congested, swelling, and the mucous gland secretions increase can ooze out with serosity, therefore mucomembranous surface can be coated with secretions, around blood vessel and the mucous gland multinuclear leucocyte or lymphocytic infiltration can be arranged under the mucosa, and mucosa swelling is plump.The pharynx wall lymphoid tissue is congested swelling also.The soft palate edema can appear in the heavier patient of pathological changes, with pharynx wall point-like exudate.Cervical lymph node also enlargement can occur.
Chronic pharyngitis (Chronic pharyngitis) is mainly pharynx mucosa chronic inflammatory disease, and diffuse inflammation often is the part of chronic other property inflammation of upper respiratory tract, and the limitation inflammation is many inflammation with the pharynx lymphoid tissue then.Chronic pharyngitis is a kind of commonly encountered diseases, frequently-occurring disease clinically, and is relatively more obstinate in the Drug therapy of routine, and repeatedly outbreak, and flu increases the weight of, and is common with middle age.
Show as pharyngeal mucosa chronic congestion.Pathological changes mainly concentrates on pharyngeal mucous layer, has more lymphoid tissue to infiltrate around its blood vessel, also visible leukocyte and plasmocyte infiltrating.Connective tissue proliferation under mucosa and the mucosa can be loose with mucous gland, glandular secretion hyperfunctioning, mucus secretion increasing and than thickness.
All persons that has the above-mentioned symptom all can be used as the standard of selecting case, and give treatment by Chinese herbs of the present invention.
Two, diagnostic criteria
Pharyngitis is that the lung stomach has intrinsic heat, and is burning hot scorching, and QI and blood is tied in throat, visible local chronic congestion, and mucosa is dry and fall ill.Other deficiency of kidney-YIN, hyperactivity of deficient fire, dry laryngopharynx, snoring can be sent out for a long time and also and is pharyngitis, and all have above-mentioned one described chronic pharyngitis, an acute pharyngitis symptom, and all diagnosis has pharyngitis.
Three, therapeutic scheme
Allly make a definite diagnosis the patient who suffers from pharyngitis, all treat with Chinese medicine of the present invention, patient every day 3 times, the morning, noon and afternoon each 1 time, each 3-5 grain, every 0.5g, 7 days is a course for the treatment of, 2-3 adds up curative effect after the course for the treatment of.
Four, efficacy assessment standard
Cure: the pharyngitis transference cure, physical recovery is healthy.
Effectively: the pharyngitis symptom is improved or obviously improves, but needs to continue the medication treatment.
Invalid: the pharyngitis symptom needs alternative to select the other medicines treatment without improvement.
Five, statistical procedures
Clinical pharyngitis patient 318 people are treated, acute pharyngitis patient 160 people wherein, patients with chronic pharyngitis 158 people treat by above-mentioned three, therapeutic scheme, and the statistical disposition result is as follows after 3 courses for the treatment of:
In the middle of above-mentioned treatment, acomia existing any untoward reaction.
Six, conclusion
Shown by above-mentioned situation, Chinese medicine drug safety of the present invention, stable curative effect is reliable, particularly in the acute pharyngitis patient treatment, has all obtained the useful therapeutic effect of distinct program, and symptom all has clear improvement and improves, and cure rate is up to 95%; And treatment of chronic pharyngitis has also been obtained very satisfied effect, effective percentage is the active drug for the treatment of pharyngitis also more than 98%, has good clinical meaning, is the greatly innovation on the treatment pharyngitis medicine, and significant economic and social benefit is arranged.

Claims (7)

1. Chinese medicine for the treatment of pharyngitis, it is characterized in that, formed by following material medicine: Squama Manis 6--18 gram, Rhizoma Belamcandae 9--12 gram, Cortex Magnoliae Officinalis 6--15 gram, Radix Platycodonis 9--12 gram, Fructus Arctii 6--10 gram, Radix Sophorae Tonkinensis 8--15 gram, Rhizoma Paridis 6--12 gram, Radix Adenophorae (Radix Glehniae) 9--12 gram, Rhizoma Polygonati Odorati 6--10 gram, Radix Scrophulariae 6--12 gram, Semen Oroxyli 8--12 gram, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
2. the Chinese medicine for the treatment of pharyngitis according to claim 1, it is characterized in that, formed by following material medicine: Squama Manis 6-10 gram, Rhizoma Belamcandae 9-10 gram, Cortex Magnoliae Officinalis 6-8 gram, Radix Platycodonis 9-10 gram, Fructus Arctii 6-7 gram, Radix Sophorae Tonkinensis 8-10 gram, Rhizoma Paridis 6-8 gram, Radix Adenophorae (Radix Glehniae) 9-10 gram, Rhizoma Polygonati Odorati 6-7 gram, Radix Scrophulariae 6-8 gram, Semen Oroxyli 8-9 gram, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
3. the Chinese medicine for the treatment of pharyngitis according to claim 1, it is characterized in that, formed by following material medicine: Squama Manis 11-15 gram, Rhizoma Belamcandae 11-12 gram, Cortex Magnoliae Officinalis 9-12 gram, Radix Platycodonis 11-12 gram, Fructus Arctii 8-9 gram, Radix Sophorae Tonkinensis 10-12 gram, Rhizoma Paridis 9-10 gram, Radix Adenophorae (Radix Glehniae) 11-12 gram, Rhizoma Polygonati Odorati 8-9 gram, Radix Scrophulariae 9-10 gram, Semen Oroxyli 10-12 gram, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
4. the Chinese medicine for the treatment of pharyngitis according to claim 1, it is characterized in that, formed by following raw material Chinese medicine: Squama Manis 16-18 gram, Rhizoma Belamcandae 12 grams, Cortex Magnoliae Officinalis 13-15 gram, Radix Platycodonis 12 grams, Fructus Arctii 10 grams, Radix Sophorae Tonkinensis 13-15 gram, Rhizoma Paridis 11-12 gram, Radix Adenophorae (Radix Glehniae) 12 grams, Rhizoma Polygonati Odorati 10 grams, Radix Scrophulariae 11-12 gram, Semen Oroxyli 11.5 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
5. the Chinese medicine for the treatment of pharyngitis according to claim 1, it is characterized in that, formed by following raw material Chinese medicine: Squama Manis 8 grams, Rhizoma Belamcandae 9 grams, Cortex Magnoliae Officinalis 1 gram, Radix Platycodonis 9 grams, Fructus Arctii 7 grams, Radix Sophorae Tonkinensis 9 grams, Rhizoma Paridis 7 grams, Radix Adenophorae (Radix Glehniae) 9 grams, Rhizoma Polygonati Odorati 7 grams, Radix Scrophulariae 7 grams, Semen Oroxyli 9 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
6. the Chinese medicine for the treatment of pharyngitis according to claim 1, it is characterized in that, formed by following raw material Chinese medicine: Squama Manis 13 grams, Rhizoma Belamcandae 10 grams, Cortex Magnoliae Officinalis 10.5 grams, Radix Platycodonis 10 grams, Fructus Arctii 8 grams, Radix Sophorae Tonkinensis 11.5 grams, Rhizoma Paridis 9.5 grams, Radix Adenophorae (Radix Glehniae) 10 grams, Rhizoma Polygonati Odorati 8 grams, Radix Scrophulariae 9.5 grams, Semen Oroxyli 10 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
7. the Chinese medicine for the treatment of pharyngitis according to claim 1, it is characterized in that, formed by following raw material Chinese medicine: Squama Manis 17 grams, Rhizoma Belamcandae 11 grams, Cortex Magnoliae Officinalis 14 grams, Radix Platycodonis 11 grams, Fructus Arctii 9 grams, Radix Sophorae Tonkinensis 14 grams, Rhizoma Paridis 11.5 grams, Radix Adenophorae (Radix Glehniae) 11 grams, Rhizoma Polygonati Odorati 9 grams, Radix Scrophulariae 11.5 grams, Semen Oroxyli 11 grams, above material medicine was ground into the smalls of 80-120 mesh sieve, incapsulate every 0.5g.
CN201310013733.4A 2013-01-15 2013-01-15 Chinese medicament for treating pharyngitis Expired - Fee Related CN103041166B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310013733.4A CN103041166B (en) 2013-01-15 2013-01-15 Chinese medicament for treating pharyngitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310013733.4A CN103041166B (en) 2013-01-15 2013-01-15 Chinese medicament for treating pharyngitis

Publications (2)

Publication Number Publication Date
CN103041166A true CN103041166A (en) 2013-04-17
CN103041166B CN103041166B (en) 2014-04-16

Family

ID=48054177

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310013733.4A Expired - Fee Related CN103041166B (en) 2013-01-15 2013-01-15 Chinese medicament for treating pharyngitis

Country Status (1)

Country Link
CN (1) CN103041166B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104338011A (en) * 2013-08-01 2015-02-11 济南伟传信息技术有限公司 Traditional Chinese medicine for treating chronic pharyngitis
CN105169157A (en) * 2015-09-15 2015-12-23 万芙潇 Traditional Chinese medicine for treating pharyngitis and preventing repetition
CN106334114A (en) * 2016-08-08 2017-01-18 青岛友诚高新技术有限公司 Traditional Chinese medicine for treating pharyngitis and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张彬 等: "《中医金方系列 五官科金方》", 31 July 2001 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104338011A (en) * 2013-08-01 2015-02-11 济南伟传信息技术有限公司 Traditional Chinese medicine for treating chronic pharyngitis
CN105169157A (en) * 2015-09-15 2015-12-23 万芙潇 Traditional Chinese medicine for treating pharyngitis and preventing repetition
CN106334114A (en) * 2016-08-08 2017-01-18 青岛友诚高新技术有限公司 Traditional Chinese medicine for treating pharyngitis and preparation method thereof

Also Published As

Publication number Publication date
CN103041166B (en) 2014-04-16

Similar Documents

Publication Publication Date Title
CN102114180B (en) Chinese medicinal oral decoction for treating chronic pharyngitis
CN102114197A (en) Traditional Chinese medicine oral decoction for treating influenza
CN104523865A (en) Medicine for treating breast diseases
CN102188685B (en) Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof
CN103721197B (en) A kind of Chinese medicine for the treatment of chronic pharyngitis
CN103099944A (en) Drug for treating stubborn insomnia
CN103041166B (en) Chinese medicament for treating pharyngitis
CN102274389B (en) Chinese medicinal composition for treating chronic pharyngitis
CN104547496A (en) Traditional Chinese medicine composition for moistening lung to arrest cough and preparation method thereof
CN103948680A (en) Suppository used for treating lung cold-type rhinitis, and preparation method thereof
CN103566096A (en) Traditional Chinese medicine (TCM) oral liquid for treating rhinitis and preparation method thereof
CN103566009A (en) Traditional Chinese medicine (TCM) composition for treating acute and chronic rhinitis
CN104800714A (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN102688384B (en) Traditional Chinese medicine decoction for treating chronic pharyngitis
CN104491384A (en) Medicine for treating chronic pharyngitis and preparation method of medicine
CN102631450B (en) Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold
CN103845592A (en) Traditional Chinese medicine for treating cervical lymph node tuberculosis
CN103768368B (en) A kind of Chinese medicine composition treating acute epididymitis
CN102488832B (en) Traditional Chinese medicine composition for treating mastitis
CN105796891A (en) Traditional Chinese medicinal composition for treating epigastric pain
CN104189268A (en) Chinese medicinal preparation for treating postpartum irregular menstruation
CN102139062A (en) Novel traditional Chinese medicine for treating pharyngitis and tonsillitis
CN105998608A (en) Traditional Chinese medicine composition for treating rhinitis
CN105288171A (en) Pharmaceutical composition for treating male climacteric syndrome
CN104257898A (en) Traditional Chinese medicine preparation for treating irregular postpartum menstruation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140416

Termination date: 20150115

EXPY Termination of patent right or utility model